The rise in diabetic neuropathy over the last few decades has paralleled the obesity and related diabetes pandemics, one expert says, and neurologists have a role to play in controlling it.
The data represent the longest follow-up available for spinal cord stimulation at a frequency higher than 60 Hz, which was the frequency initially approved by the FDA.